RU2006117777A - Композиции для лечения поражений полости рта и верхних дыхательных путей - Google Patents

Композиции для лечения поражений полости рта и верхних дыхательных путей Download PDF

Info

Publication number
RU2006117777A
RU2006117777A RU2006117777/15A RU2006117777A RU2006117777A RU 2006117777 A RU2006117777 A RU 2006117777A RU 2006117777/15 A RU2006117777/15 A RU 2006117777/15A RU 2006117777 A RU2006117777 A RU 2006117777A RU 2006117777 A RU2006117777 A RU 2006117777A
Authority
RU
Russia
Prior art keywords
composition according
extract
phloroglucinol
procyanidins
anthocyanosides
Prior art date
Application number
RU2006117777/15A
Other languages
English (en)
Other versions
RU2369401C2 (ru
Inventor
Эцио БОМБАРДЕЛЛИ (IT)
Эцио БОМБАРДЕЛЛИ
Original Assignee
Индена С.П.А. (It)
Индена С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индена С.П.А. (It), Индена С.П.А. filed Critical Индена С.П.А. (It)
Publication of RU2006117777A publication Critical patent/RU2006117777A/ru
Application granted granted Critical
Publication of RU2369401C2 publication Critical patent/RU2369401C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Claims (15)

1. Композиции для лечения поражений полости рта и верхних дыхательных путей, содержащие:
a) антоцианозиды и/или
b) процианидины и
c) флороглюцинолы.
2. Композиции по п.1, содержащие:
a) от 1 до 200 мг антоцианозидов и/или
b) от 1 до 200 мг процианидинов и
c) от 1 до 200 мг флороглюцинолов.
3. Композиции по пп.1 и 2, в которых антоцианозиды происходят из экстракта Vaccinium myrtillus.
4. Композиции по пп.1-2, в которых процианидины извлечены из экстракта Vitis vinifera или экстракта Camellia sinensis, или других содержащих их съедобных растений.
5. Композиции по пп.1 и 2, в которых флороглюцинолы происходят из экстрактов видов Hypericum, видов Mirtus или Humulus lupulus.
6. Композиции по п.5, в которых флороглюцинолы происходят из экстрактов Hypericum perforatum или Mirtus communis, или из фракций Humulus lupulus, обогащенных α и β кислотами.
7. Композиции по п.6, в которых фракция β кислот из Humulus lupulus содержит от 20 до 80% флороглюцинолов, представленных колупулоном, и фракция α кислот содержит от 20 до 80% гумулона.
8. Композиции по п.7, в которых фракция β кислот, полученных из Humulus lupulus содержит 60% флороглюцинолов, представленных колупулоном, и фракция α кислот содержит 60% гумулона.
9. Композиции по пп.1-2, в которых экстракт вида Hypericum представляет собой экстракт Hypericum perforatum с содержанием флороглюцинолов в пределах от 20 до 80%.
10. Композиции по п.9, в которых содержание флороглюцинолов в экстракте Hypericum perforatum составляет 60%.
11. Композиции по п.6, в которых экстракт Mirtus communis получен из листьев, экстракцией с помощью диоксида углерода при давлении в диапазоне 235-260 бар и температуре от 40 до 60°C.
12. Композиции по п.11, в которых экстракт Mirtus communis содержит миртокумолон в количестве 35%.
13. Композиции по пп. 1 и 2, дополнительно содержащие эфирные масла.
14. Композиции по п.13, в которых эфирное масло представляет собой масло мяты.
15. Применение комбинации
a) антоцианозидов и/или
b) процианидинов и
c) флороглюцинолов
для получения лекарственных средств для лечения поражений полости рта и верхних дыхательных путей.
RU2006117777/15A 2003-11-24 2004-11-04 Композиции для лечения поражений полости рта и верхних дыхательных путей RU2369401C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002287A ITMI20032287A1 (it) 2003-11-24 2003-11-24 Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI2003A002287 2003-11-24

Publications (2)

Publication Number Publication Date
RU2006117777A true RU2006117777A (ru) 2007-12-10
RU2369401C2 RU2369401C2 (ru) 2009-10-10

Family

ID=34640361

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006117777/15A RU2369401C2 (ru) 2003-11-24 2004-11-04 Композиции для лечения поражений полости рта и верхних дыхательных путей

Country Status (21)

Country Link
US (1) US7910139B2 (ru)
EP (1) EP1687015B1 (ru)
JP (1) JP4960100B2 (ru)
KR (1) KR101181119B1 (ru)
CN (1) CN1886147A (ru)
AT (1) ATE454167T1 (ru)
AU (1) AU2004294688B2 (ru)
CA (1) CA2546926C (ru)
DE (1) DE602004025031D1 (ru)
DK (1) DK1687015T3 (ru)
ES (1) ES2335414T3 (ru)
IL (1) IL175845A0 (ru)
IT (1) ITMI20032287A1 (ru)
NO (1) NO339625B1 (ru)
NZ (1) NZ547396A (ru)
PL (1) PL1687015T3 (ru)
PT (1) PT1687015E (ru)
RU (1) RU2369401C2 (ru)
SG (1) SG148194A1 (ru)
SI (1) SI1687015T1 (ru)
WO (1) WO2005053719A2 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007067812A2 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
WO2008026473A1 (en) * 2006-08-31 2008-03-06 Asahi Breweries, Ltd. Method for production of hop preparation, hop preparation, antiinflammatory agent, food/beverage, and oral product
GB0623619D0 (en) * 2006-11-27 2007-01-03 Mars Uk Ltd Composition
ITSS20090007A1 (it) * 2009-03-25 2010-09-25 Sardinia Res And Dev S R L Utilizzo dell'estratto di myrtus communis per la terapia dell'influenza tipo a.
IT1402018B1 (it) * 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
GB201108384D0 (en) 2011-05-18 2011-06-29 Mars Inc Chew
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
GB201310691D0 (en) 2013-06-14 2013-07-31 Mars Inc Assay
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
BR112019009089A2 (pt) 2016-11-03 2019-07-16 Univ Cornell composição cosmética, método para tratar queimaduras solares, sinais de envelhecimento ou uma combinação destes em mamíferos e método para aprimorar reparo de dna
US11013673B2 (en) 2016-11-03 2021-05-25 Repairogen Corp. Cosmetic compositions containing quinones and their topical use on skin and hair
WO2019213494A1 (en) 2018-05-03 2019-11-07 Repairogen Corp Cosmetic compositions containing quinones and their topical use on skin and hair
CN109172556A (zh) * 2018-10-30 2019-01-11 何凤姣 一种治疗口腔溃疡的组合物及其制备方法
BR112022005064A2 (pt) 2019-09-30 2022-06-21 Procter & Gamble Métodos de uso de composições para tratamento bucal que compreendem lúpulo
WO2021062607A1 (en) 2019-09-30 2021-04-08 The Procter & Gamble Company Oral care compositions comprising hops beta acid and amino acid
WO2023057556A1 (de) * 2021-10-07 2023-04-13 Dr. Eckel Vermögensverwaltung Gmbh Zusammensetzung zur reduzierung der konzentration von viren und des afrikanischen schweinepest-virus (african swine fever virus, asfv) in tierfutter und einstreumaterial für ställe
EP4176730A1 (de) * 2021-10-07 2023-05-10 Dr. Eckel Vermögensverwaltung GmbH Zusammensetzung zur reduzierung der konzentration von viren und des afrikanischen schweinepest-virus (african swine fever virus, asfv) in tierfutter und einstreumaterial für ställe
KR102517602B1 (ko) * 2022-10-31 2023-04-04 한국 한의학 연구원 포도나무 줄기 및 유래성분을 함유하는 항바이러스 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
US4503256A (en) * 1981-07-02 1985-03-05 Noristan Limited Phlorophenone derivatives, processes for preparing such compounds, uses and pharmaceutical compositions of phlorophenone compounds
FR2571257A1 (fr) * 1984-08-06 1986-04-11 Gros Pierre Composition destinee a l'humidification de la muqueuse rhino-pharyngee
SU1373398A1 (ru) * 1986-07-24 1988-02-15 Технологическо-Конструкторский Институт Научно-Производственного Агропромышленного Объединения "Яловены" Безалкогольный газированный напиток
US5650432A (en) * 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
JPH06179609A (ja) * 1992-12-14 1994-06-28 Lion Corp 口腔用組成物
US5370863A (en) * 1992-12-16 1994-12-06 Miller Brewing Company Oral care compositions containing hop acids and method
US5474774A (en) * 1994-03-25 1995-12-12 Jlb, Inc. Adhesion inhibiting composition
JPH0820518A (ja) 1994-07-06 1996-01-23 Shiseido Co Ltd 染毛剤組成物
JP2901879B2 (ja) * 1994-07-12 1999-06-07 株式会社ポッカコーポレーション 抗菌剤
JP3450080B2 (ja) * 1995-02-01 2003-09-22 有限会社野々川商事 プロシアニジンを配合した健康食品および医薬品
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
JP3547835B2 (ja) 1995-03-27 2004-07-28 株式会社ロッテ 喉炎症・溶血毒の予防・治療剤およびこれを含有する口腔用組成物
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
US5955102A (en) * 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants
US6224906B1 (en) * 1999-08-31 2001-05-01 Natreon Inc. St. John's wort composition
US6379720B1 (en) * 2000-07-18 2002-04-30 Nalco Chemical Company Compositions containing hops extract and their use in water systems and process streams to control biological fouling
AU8452701A (en) * 2000-09-12 2002-03-26 Nikka Whisky Distilling Co Ltd Wild apple polyphenol and process for producing the same
AU2002311922A1 (en) * 2001-05-15 2002-11-25 The Procter And Gamble Company Oral care compositions
US6576269B1 (en) * 2001-09-06 2003-06-10 Alexander Y. Korneyev Treating open skin lesions using extract of sea buckthorn
US6638542B2 (en) * 2001-09-20 2003-10-28 Nutricia N.V. Reducing appetite in mammals by administering procyanidin and hydroxycitric acid
US6623768B1 (en) * 2002-04-16 2003-09-23 Yousry M. A. Naguib Pharmaceutically active composition extracted from Ferula hermonis and process of its extraction
CN1191848C (zh) * 2002-12-23 2005-03-09 桂林三金药业股份有限公司 一种防治咽喉口腔疾病的中药制剂及其制备方法

Also Published As

Publication number Publication date
AU2004294688A1 (en) 2005-06-16
JP4960100B2 (ja) 2012-06-27
EP1687015B1 (en) 2010-01-06
CA2546926C (en) 2014-09-23
DE602004025031D1 (de) 2010-02-25
ITMI20032287A1 (it) 2005-05-25
DK1687015T3 (da) 2010-05-03
NO339625B1 (no) 2017-01-16
KR20070007252A (ko) 2007-01-15
CA2546926A1 (en) 2005-06-16
CN1886147A (zh) 2006-12-27
NO20062355L (no) 2006-05-23
ATE454167T1 (de) 2010-01-15
RU2369401C2 (ru) 2009-10-10
US7910139B2 (en) 2011-03-22
SI1687015T1 (sl) 2010-04-30
ES2335414T3 (es) 2010-03-26
AU2004294688B2 (en) 2010-07-22
JP2007512268A (ja) 2007-05-17
WO2005053719A3 (en) 2005-09-22
IL175845A0 (en) 2006-10-05
PL1687015T3 (pl) 2010-05-31
PT1687015E (pt) 2010-01-27
NZ547396A (en) 2009-04-30
KR101181119B1 (ko) 2012-09-14
US20070104661A1 (en) 2007-05-10
SG148194A1 (en) 2008-12-31
EP1687015A2 (en) 2006-08-09
WO2005053719A2 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
RU2006117777A (ru) Композиции для лечения поражений полости рта и верхних дыхательных путей
IL175846A (en) Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
Okokon et al. Antiplasmodial activity of root extract and fractions of Croton zambesicus
Mohammed Comparative study of in vitro antibacterial activity of miswak extracts and different toothpastes
US20160174603A1 (en) Electronic Vapor Liquid Composition and Method of Use
Chauhan et al. A review: Nutraceuticals properties of Piper betel (Paan)
Gadamsetty et al. Antioxidant and Anti-inflammatory Activities of the Methanolic Leaf Extract of Traditionally Used Medicinal Plant Mimusops elengi L.
Calvo et al. The pharmacological validation of medicinal plants used for digestive problems in Navarra, Spain
Hamid et al. Screening of different parts of the plant Pandanus odorus for its antioxidant activity
Khalaf et al. Antioxidant, anti-inflammatory and anti-diarrheal activity of ethanolic extract of medicinal plants grown in Jordan and Palestine
Naseri Anti-halitosis plants in Iranian traditional medicine
Dutta et al. Studies on secondary metabolites, total phenol and flavonoid contents of Eupatorium cannabinum L. in Assam, India
Aly et al. Antimicrobial and Preliminary Phytochemical investigation of Galenia asiatica (Mustard bush)
RU97113011A (ru) Состав и способ получения средства "фитодент" для лечения заболеваний пародонта
Ayofe et al. Comparative studies on In-vitro radical scavenging potential of methanol extracts of Garcinia kola heck (Clusiaceae) seeds, Conyza sumatrensis retz (Asteraceae) and Mitracarpus scaber zucc (Rubiaceae) leaves
Kweera et al. Phytochemical analysis and in vitro antibacterial activity of Swertia chirayta whole plant in different solvents
Patrick Antioxidant effects of methanolic stem-bark extract of Pterocarpus erinaceus on gastric acid secretion
DONKOR et al. EFFECT OF ETHANOL STEM BARK EXTRACT OF BERLINIA GRANDIFLORA HUTCH AND DALZ ON MARKER LIVER ENZYMES IN RATS TREATED WITH CCl
Mudimba Study of Phytochemistry, Toxicity and Antihypertensive Activity of Carpobrotus Edulis Aqueous Leaf Extract
Madhavan et al. Pharmacognostical studies on the adventitious roots of Pandanus fascicularis Lam.(Pandanaceae)
عماد هادي حميد الطائي Antimicrobial, Anti-inflammatory, Analgesic Potential and Cytotoxic Activity of Salvadora persica A Review
Marathe et al. The therapeutic action of queen of herb (Ocimum tenuiflorum)
WO2022260632A3 (en) Herbal cream containing hypericum perforatum oil and propolis
Burakova et al. Antibacterial activity of Geranium pratense preparations
Ibrahim Selected Phytochemical, Nutritional and Antioxidant Properties of Fresh, Oven and Freeze-dried Streblus Asper Leaves